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The National Department of Health has promulgated the 
first week of August as National Rheumatic Fever Week ever 
since rheumatic fever was made a notifiable condition in 1989. 
The results of the Heart of Soweto Study, however, show that 
very little progress has been made in reducing the burden of 
rheumatic heart disease over the past 20 years. This prospective 
study of 4 005 patients with heart disease who presented at 
Chris Hani Baragwanath Hospital during 2006/07 showed 
that 960 (24%) had valvular heart disease.1 The incidence of 
new cases of rheumatic heart disease for those aged >14 years 
in Soweto was 23.5 cases/100 000 per annum, which puts this 
urban community among the high-incidence communities of 
the world. It is not surprising that this preventable condition 
remains common, because of inadequate implementation of 
the guideline for the prevention of rheumatic fever in South 
Africa.2 A recent study showed that very few paediatricians 
were aware that rheumatic fever is a notifiable condition, 
and that the national notification system administered by the 
Department of Health was dysfunctional.3
What is to be done? 
Rheumatic Fever Week 2010 offers health professionals, 
administrators and planners an opportunity to re-discover 
the four pillars of control of rheumatic fever and rheumatic 
heart disease, which are enunciated in the national guideline 
for the prevention of rheumatic fever in primary care.4 The 
first pillar is education of the public, health care professionals, 
health administrators and health policy makers about the 
causes, treatment and prevention of rheumatic fever. Public 
and professional education in particular leads to better case 
ascertainment and is the essential first step for a successful 
prevention programme.5 The second pillar is primary 
prevention through treatment of suspected streptococcal sore 
throat with penicillin, based on a syndromic approach to the 
assessment of pharyngitis.6 This approach was applied to great 
effect in Costa Rica and Cuba.7,8
The third pillar of rheumatic fever and rheumatic heart 
disease control is secondary prevention through register-
based penicillin prophylaxis.9 It is critical that all health 
centres have registers of their patients with rheumatic fever 
and rheumatic heart disease to ensure compliance with 
secondary prophylaxis with penicillin. It is also important to 
know that lifelong penicillin prophylaxis is recommended for 
patients with a history of heart failure or previous surgery 
for rheumatic heart disease.10 Finally, the fourth pillar of 
an effective prevention strategy is surveillance through 
notification of acute rheumatic fever, which is mandatory in 
terms of South Africa law.3 Unfortunately over 50% of patients 
with rheumatic heart disease do not have a history of acute 
rheumatic fever. Making the first episode of rheumatic heart 
disease a notifiable condition should therefore be considered.1 
The addition of the first episode of rheumatic heart disease as a 
notifiable condition would provide a complete national picture 
of the incidence of rheumatic fever and rheumatic heart disease 
in South Africa.
South Africa needs to learn from the examples of Cuba, 
Costa Rica, and the French Caribbean islands of Martinique 
and Guadeloupe, who have implemented a comprehensive 
strategy based on the four pillars of rheumatic heart disease 
control, which has resulted in the virtual elimination of the 
disease in their countries within 10 - 15 years.5,7,8 Africa has 
lagged behind the other regions of the world in rheumatic 
fever control, partially because of neglect of the widespread 
treatment of suspected streptococcal sore throat with 
penicillin.6 The Pan African Society of Cardiology has called on 
the Ministries of Health in Africa to implement a programme 
of Awareness Raising, Surveillance, Advocacy and Prevention 
(the A.S.A.P. Programme) to deal with the scourge of the 
disease on the continent.11,12 The time has come for health 
care professionals, policy makers and the public to join the 
campaign to make rheumatic fever history in our lifetime.
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